# Can Blood Thinners Make Periods Heavier? What the Evidence Says

> Can blood thinners make periods heavier? See what anticoagulant studies show, signs to report, when to seek urgent care, and why treatment changes need a clinician.

![Can Blood Thinners Make Periods Heavier? What the Evidence Says](https://gender-medicine-gap.nicheflash.com/media/articles/2780-6hvwjowdzu3z-16x9.jpg)

- Source: https://gender-medicine-gap.nicheflash.com/blogs/can-blood-thinners-make-periods-heavier
- Author: [Gender Medicine Gap Editorial Team](https://gender-medicine-gap.nicheflash.com/authors/gender-medicine-gap-editorial-team)
- Publisher: Gender Medicine Gap
- Published: 2026-10-19
- Updated: 2026-10-19

Yes. Anticoagulants can be associated with heavier menstrual bleeding. “Blood thinner” is an informal umbrella term; this article focuses mainly on anticoagulants, especially direct oral anticoagulants (DOACs). The drug comparison discussed here involved a small group of patients with venous thromboembolism (VTE), so its findings do not apply equally to every medicine called a blood thinner. Do not stop or change your medication on your own. [1]

 - New or worsening menstrual bleeding while taking an anticoagulant is worth discussing with the clinician who prescribes it. [2][1]
- One small study found higher average bleeding scores with rivaroxaban than with apixaban, but it cannot identify the best drug for an individual. [3]
- Bleeding that disrupts daily life, lasts longer than usual, or comes with symptoms such as faintness deserves medical attention.
- Seek urgent assessment for very heavy ongoing bleeding or symptoms such as fainting, marked weakness, shortness of breath, or chest pain.
- Do not skip doses or start a treatment such as tranexamic acid unless your treating clinician recommends it. [4][1]

 ## What counts as heavy menstrual bleeding?

 Heavy menstrual bleeding (HMB) means bleeding experienced as unusually heavy or disruptive. Definitions and measurement methods vary between studies and clinical settings. [3][1] HMB is not a label for every kind of uterine bleeding, and taking an anticoagulant does not rule out other causes that may need assessment. [2][1]

 Consider contacting a clinician if your period is disrupting work, school, sleep, or other daily activities; you need to change menstrual products unusually often; bleeding lasts longer than is normal for you; or you feel unusually tired, weak, dizzy, or short of breath. These are prompts for assessment, not a diagnosis or a fixed threshold for HMB.

 The HEMBLED Registry used a pictorial blood assessment chart (PBAC) and treated a score above 100 points as its study threshold for HMB. [3] That cutoff describes how this particular study classified bleeding; it is not a universal diagnostic rule. The registry excluded people using hormonal or intrauterine contraception, which limits how broadly its findings can be applied. [3]

 ## Can blood thinners make periods heavier, and does the drug matter?

 Anticoagulant treatment can be associated with heavier menstrual bleeding. A small prospective study found different average bleeding scores for two drugs, but that association does not prove what caused an individual person’s bleeding. [3]

 The HEMBLED Registry followed 73 menstruating patients with VTE taking therapeutic-dose DOACs for four months. [3] Mean PBAC scores were 145 points with rivaroxaban and 93 points with apixaban. The rivaroxaban mean was 54% higher, a statistically significant difference in this study (p = 0.0193). [3] At least once during follow-up, HMB was recorded in 79% of the rivaroxaban group and 53% of the apixaban group; this difference was not statistically significant (p = 0.0913). [3]

 The study included only 19 people taking rivaroxaban, and the researchers noted possible selection and reporting bias. Five participants took edoxaban and four took dabigatran. [3] The results suggest a possible difference between rivaroxaban and apixaban in this study, not a prediction of personal risk or a reason to switch medication without clinical advice.

 ## How do patients describe the impact of bleeding?

 A survey documents how some patients with HMB while taking anticoagulants described its effects and their treatment decisions. It cannot show how common those experiences are among all patients. [5]

 83% identified thrombotic risk as the most important factor when considering treatment options. [5]

 The findings describe these respondents’ experiences and preferences; they do not establish treatment effectiveness or safety. They do show why a care discussion should consider both bleeding and clotting concerns.

 ## What should you do if bleeding gets heavier while taking an anticoagulant?

 Contact the prescribing clinician about new or worsening menstrual bleeding rather than skipping doses, stopping early, or changing drugs without medical guidance. [1]

 Seek urgent medical assessment if bleeding is very heavy and ongoing, or if you feel faint, unusually weak, short of breath, or have chest pain. If you faint or feel severely unwell, seek emergency care. Do not wait for a routine appointment when these symptoms occur.

 1. Describe what has changed, when it began, how long it lasts, and how it affects daily life. An expert toolkit recommends discussing menstrual bleeding when anticoagulation starts and revisiting it during follow-up. [2]
2. Ask whether a bleeding history, complete blood count, or ferritin check is appropriate. The toolkit recommends evaluating iron deficiency, and an American Society of Hematology review advises a blood count and ferritin check when symptoms warrant evaluation. [2][1]
3. Ask whether other gynecologic or bleeding-related causes should be considered. Anticoagulant use alone does not establish the cause. [2][1]
4. Discuss care with the clinicians involved; collaboration between hematology and gynecology may be appropriate. [2]

 The American Society of Hematology review cautions that temporary or early discontinuation of anticoagulation can increase the risk of recurrent VTE and is not recommended. [1]

 ## Which treatments can clinicians discuss, and how strong is the evidence?

 Clinicians may consider anticoagulant choice and menstrual treatments based on the person’s circumstances. Evidence about care and specific interventions remains limited. [4][2]

 An expert toolkit describes its recommendations as expert opinion and notes a near total lack of data on care delivery in this population. [2] The MEDEA randomized clinical trial assigned 16 participants among three approaches: switching to dabigatran, taking tranexamic acid during menstruation while continuing a factor Xa inhibitor, or continuing the factor Xa inhibitor without intervention. [4]

 Mean PBAC-score changes were −183 points with dabigatran (4 participants; 95% confidence interval [CI] −487 to 121), −199 points with tranexamic acid (5 participants; 95% CI −343 to −54), and +30 points with no intervention (7 participants; 95% CI −336 to 396). [4] The trial stopped early because of low enrollment and was not adequately powered; its authors described the findings as hypothesis-generating and said they could not draw solid conclusions. [4] These small groups do not establish either approach as standard treatment.

 Do not take tranexamic acid for menstrual bleeding while on an anticoagulant unless your treating clinician recommends it. Its use in this situation requires an individualized, clinician-led decision, particularly given the limited evidence and the need to consider VTE history. [4]

 The toolkit also cautions that abruptly stopping hormonal menstrual therapy can trigger withdrawal bleeding. [2] Discuss hormonal treatment and anticoagulation with your clinicians rather than stopping either abruptly. [2]

 ## Frequently asked questions

 ### Does the HEMBLED comparison apply to people using hormonal contraception or an intrauterine device?

 Not directly. The HEMBLED Registry excluded people using hormonal or intrauterine contraception, so it cannot establish what bleeding patterns or drug differences apply to them. [3]

 ### Should I stop hormonal treatment that helps control my periods when anticoagulation starts?

 Do not stop it abruptly without discussing a plan with your treating clinicians. The expert toolkit warns that abrupt discontinuation can trigger withdrawal bleeding. [2]

 ### Does evidence about heavy periods also apply to bleeding between periods or after menopause?

 The cited studies and guidance focus on menstrual bleeding in people who menstruate, so they do not establish how to assess bleeding between periods or after menopause.[1] Ask a clinician to assess those symptoms rather than assuming they are an anticoagulant effect.

## References

1. [ashpublications.org](https://ashpublications.org/hematology/article/2022/1/467/493547/Anticoagulant-therapy-for-women-implications-for)
2. [pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC12490520/)
3. [pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC13521661/)
4. [pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11215107/)
5. [pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/40816247/)